Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-21,205
Closed -$5.57M 70
2022
Q4
$5.57M Buy
21,205
+53
+0.3% +$14.2K 4.1% 6
2022
Q3
$4.77M Sell
21,152
-768
-4% -$186K 3.69% 11
2022
Q2
$5.33M Buy
+21,920
New +$5.37M 3.6% 10
2020
Q3
Sell
-7
Closed -$2K 171
2020
Q2
$2K Buy
+7
New +$1.6K ﹤0.01% 238
2020
Q1
Sell
-11
Closed -$3K 160
2019
Q4
$3K Buy
+11
New +$2.42K ﹤0.01% 177

Other funds holding AMGN

NWK Group's AMGN Position: Q1 2023 in Review

NWK Group sold out of Amgen (AMGN) in Q1 2023, closing a stake of 21,205 shares — an estimated $5.57M sold.

NWK Group first reported a position in AMGN in Q4 2019 and held it in 5 quarters. The position peaked at $5.57M in Q4 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • NWK Group reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • NWK Group sold 21,205 Amgen shares in Q1 2023, an estimated $5.57M.
  • NWK Group first reported a position in Amgen in Q4 2019 and held it in 5 quarters.
  • NWK Group's Amgen position peaked at $5.57M in Q4 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on NWK Group's 13F filing for Q1 2023, filed 15 May 2023.